Bedrijf laden
Keep exploring
The themes Thermo Fisher Scientific is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Diagnostics and Research
Graded A or B and worth $2B or more: A first, then the largest.
IDXXIdexx Laboratories Inc.US$ 55BA+
IQVIQVIA Holdings Inc.US$ 44,7BA
ILMNIllumina, Inc.US$ 31,7BA+
LHLabcorp Holdings Inc.US$ 30,2BA
DGXQuest Diagnostics IncUS$ 28,6BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 okt 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
BIIBBiogen Inc.28 okt 2026BAGraded B, now A
Hoe het geld verdient
- Laboratory Products and Biopharma Services53%
- Life Sciences Solutions20%
- Analytical Instruments17%
- Specialty Diagnostics10%
De omzetaandelen zijn schattingen voor year ended December 31, 2025, geen cijfers uit een ingediend rapport.
Concurreert met
Wat het verkoopt6
Thermo Scientific Orbitrap Tribrid Apex Mass Spectrometer
An instrument that measures molecules in samples to help researchers study complex biology, medicines, and other substances.
Thermo Scientific Vanquish Amplify ultra-high-performance liquid chromatography system
An instrument that separates and analyzes substances in liquid samples, including sensitive biological molecules.
Applied Biosystems PowerFlex Thermal Cycler
A laboratory instrument that repeatedly heats and cools samples to copy selected genetic material for testing or research.
Nog 3 tonen
DynaDrive single-use bioreactors
Containers and equipment used to grow cells and produce medicines; the single-use parts are replaced between production runs.
Diagnostic test kits and reagents
Tests and the chemicals needed to detect or monitor conditions such as allergies, thyroid disorders, infections, and drug levels.
PPD and Patheon services
PPD provides clinical research and clinical-trial services; Patheon develops and manufactures medicines for pharmaceutical and biotechnology customers.
Wie het koopt5
- Pharmaceutical and biotechnology companies buy research supplies, instruments, drug-development and clinical-trial services, and equipment and materials for medicine production, through direct sales and purchasing channels.
- Hospitals, clinical laboratories, and physicians’ offices buy diagnostic tests, reagents, instruments, and laboratory supplies.
- Universities, research institutions, and government agencies buy research products and scientific instruments, often using grant or government funding.
Nog 2 tonen
- Industrial and applied-science customers buy instruments and testing products for areas such as environmental testing, safety, manufacturing, and quality control.
- Food-safety and other testing laboratories buy diagnostic kits, reagents, culture media, and related instruments.
Waar het op steunt, en wat het kan breken
Waar het bedrijf van afhangt
- 1Demand depends in part on pharmaceutical and biotechnology customer spending, research budgets, government funding, and customers’ plans for buying laboratory equipment.
- 2Some materials or components come from a single supplier or a limited number of suppliers, and the company also relies heavily on third-party package-delivery services to ship products.
- 3The company relies on scientific, technical, clinical, and management employees and on complying with regulations that apply to laboratory products, diagnostics, medicine services, data, and government contracts.
- 4Its clinical research and medicine-manufacturing services depend on delivering complex work to customers on time and to required quality standards.
Wat er mis kan gaan
- 1Revenue can be affected when pharmaceutical, biotechnology, academic, government, or industrial customers reduce spending, delay equipment purchases, or face changes in research funding.
- 2The company must keep developing products and responding to technological changes and competing products while maintaining product quality; failure to do so could reduce demand.
- 3Its complex clinical research and medicine-manufacturing work can be affected by delays or quality problems, while a cyberattack or breach of information systems could disrupt operations or expose protected data.
Over Thermo Fisher Scientific Inc.
Thermo Fisher sells products and services to pharmaceutical and biotechnology companies, hospitals, clinical laboratories, universities, government agencies, and industrial customers. Its products include research supplies, instruments for analyzing samples, and diagnostic tests; its services include clinical-trial work and manufacturing medicines for customers. In the second quarter of 2026, management said customer demand had strengthened across its major markets.
- Hoofdkantoor
- Waltham, Massachusetts, United States
- Opgericht in
- 2006
- Medewerkers
- Approximately 125,000 (December 31, 2025, high)
- Genoteerd aan
- New York Stock Exchange
- Einde boekjaar
- December 31
Gebouwd uit de eigen deponeringen van Thermo Fisher Scientific Inc. bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.